COVID-19 disease occurs primarily in the alveoli, where the virus attacks type II pneumocytes, which can lead to an abnormal alveolocapillary membrane and the so-called post-COVID syndrome. A diffusion assay is the primary measurement technique used to detect this pathophysiology. Patients suffering from post-COVID syndrome complain of symptoms such as shortness of breath and fatigue, but usually have a normal spirometry reading. In these cases, diffusion testing is the method of choice to confirm the diagnosis of post-COVID syndrome, which is psychologically important for patients and a significant measure for monitoring COVID-19 rehabilitation.
The main route of transmission for SARS-CoV-2 is respiratory ingestion of virus-containing particles. When using the GANSHORN SpiroScout, contamination with viruses and bacteria is impossible. The ScoutTube, the mouthpiece of the SpiroScout, is changed after each patient. In addition, the membrane of the ScoutTube allows only ultrasound waves to pass through, virtually eliminating contamination of the device and patient.
All of our mouthpieces and nose clips are cost effective and designed for single use. To avoid possible contamination of the ambient air, the filters can optionally be used after upgrading the device.